Edesa Biotech
(NASDAQ:EDSA)
$4.20
-0.2684[-6.01%]
At close: Apr 16
$4.20
0[0.00%]
After Hours: 4:11PM EDT
Consensus Rating1
Buy
Highest Price Target1
$57.00
Lowest Price Target1
$21.00
Consensus Price Target1
$39.00

Edesa Biotech Stock (NASDAQ:EDSA), Analyst Ratings, Price Targets, Predictions

Edesa Biotech Inc has a consensus price target of $39, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on February 14, 2024, November 29, 2023, and November 22, 2023. With an average price target of $17.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 312.70% upside for Edesa Biotech Inc from these 3 analyst ratings.

Analyst Trend
2
Nov 23
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Brookline Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Edesa Biotech

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/14/2024EDSABuy Now
Edesa Biotech
$4.20400%HC Wainwright & Co.
Vernon Bernardino
→ $21ReiteratesBuy → BuyGet Alert
11/29/2023EDSABuy Now
Edesa Biotech
$4.20400%HC Wainwright & Co.
Vernon Bernardino
$70 → $21MaintainsBuyGet Alert
11/22/2023EDSABuy Now
Edesa Biotech
$4.20138.1%HC Wainwright & Co.
Vernon Bernardino
→ $10ReiteratesBuy → BuyGet Alert
10/12/2023EDSABuy Now
Edesa Biotech
$4.201257.14%Brookline Capital
Kemp Dolliver
→ $57MaintainsBuyGet Alert
08/15/2023EDSABuy Now
Edesa Biotech
$4.20138.1%HC Wainwright & Co.
Vernon Bernardino
$112 → $70MaintainsBuyGet Alert
05/24/2023EDSABuy Now
Edesa Biotech
$4.20280.95%HC Wainwright & Co.
Vernon Bernardino
→ $112ReiteratesBuy → BuyGet Alert
03/15/2023EDSABuy Now
Edesa Biotech
$4.20280.95%HC Wainwright & Co.
Vernon Bernardino
→ $112Reiterates → BuyGet Alert
02/14/2023EDSABuy Now
Edesa Biotech
$4.20280.95%HC Wainwright & Co.
Vernon Bernardino
→ $112Reiterates → BuyGet Alert
12/16/2022EDSABuy Now
Edesa Biotech
$4.20209.52%Brookline Capital
Kemp Dolliver
→ $13MaintainsBuyGet Alert
12/20/2021EDSABuy Now
Edesa Biotech
$4.20280.95%HC Wainwright & Co.
Vernon Bernardino
Initiates → BuyGet Alert

FAQ

Q

What is the target price for Edesa Biotech (EDSA)?

A

The latest price target for Edesa Biotech (NASDAQ: EDSA) was reported by HC Wainwright & Co. on February 14, 2024. The analyst firm set a price target for $21.00 expecting EDSA to rise to within 12 months (a possible 400.00% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Edesa Biotech (EDSA)?

A

The latest analyst rating for Edesa Biotech (NASDAQ: EDSA) was provided by HC Wainwright & Co., and Edesa Biotech reiterated their buy rating.

Q

When was the last upgrade for Edesa Biotech (EDSA)?

A

There is no last upgrade for Edesa Biotech.

Q

When was the last downgrade for Edesa Biotech (EDSA)?

A

There is no last downgrade for Edesa Biotech.

Q

When is the next analyst rating going to be posted or updated for Edesa Biotech (EDSA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edesa Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edesa Biotech was filed on February 14, 2024 so you should expect the next rating to be made available sometime around February 14, 2025.

Q

Is the Analyst Rating Edesa Biotech (EDSA) correct?

A

While ratings are subjective and will change, the latest Edesa Biotech (EDSA) rating was a reiterated with a price target of $0.00 to $21.00. The current price Edesa Biotech (EDSA) is trading at is $4.20, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.